Copyright Reports & Markets. All rights reserved.

Global Drug–Device Combination Products Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Drug–Device Combination Products Market Overview

      • 1.1 Product Overview and Scope of Drug–Device Combination Products
      • 1.2 Drug–Device Combination Products Segment by Type
        • 1.2.1 Global Drug–Device Combination Products Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Infusion Pumps
        • 1.2.3 Orthopedic Combination Products
        • 1.2.4 Photodynamic Therapy Devices
        • 1.2.5 Transdermal Patches
        • 1.2.6 Drug Eluting Stents
        • 1.2.7 Wound Care Products
        • 1.2.8 Inhalers
        • 1.2.9 Other
      • 1.3 Drug–Device Combination Products Segment by Application
        • 1.3.1 Drug–Device Combination Products Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Clinic
        • 1.3.4 Other
      • 1.4 Global Drug–Device Combination Products Market by Region
        • 1.4.1 Global Drug–Device Combination Products Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Drug–Device Combination Products Market Size
        • 1.5.1 Global Drug–Device Combination Products Revenue (2014-2025)
        • 1.5.2 Global Drug–Device Combination Products Production (2014-2025)

      2 Global Drug–Device Combination Products Market Competition by Manufacturers

      • 2.1 Global Drug–Device Combination Products Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Drug–Device Combination Products Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Drug–Device Combination Products Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Drug–Device Combination Products Production Sites, Area Served, Product Types
      • 2.5 Drug–Device Combination Products Market Competitive Situation and Trends
        • 2.5.1 Drug–Device Combination Products Market Concentration Rate
        • 2.5.2 Drug–Device Combination Products Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Drug–Device Combination Products Production Market Share by Regions

      • 3.1 Global Drug–Device Combination Products Production Market Share by Regions
      • 3.2 Global Drug–Device Combination Products Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Drug–Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Drug–Device Combination Products Production
        • 3.4.1 North America Drug–Device Combination Products Production Growth Rate (2014-2019)
        • 3.4.2 North America Drug–Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Drug–Device Combination Products Production
        • 3.5.1 Europe Drug–Device Combination Products Production Growth Rate (2014-2019)
        • 3.5.2 Europe Drug–Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Drug–Device Combination Products Production (2014-2019)
        • 3.6.1 China Drug–Device Combination Products Production Growth Rate (2014-2019)
        • 3.6.2 China Drug–Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Drug–Device Combination Products Production (2014-2019)
        • 3.7.1 Japan Drug–Device Combination Products Production Growth Rate (2014-2019)
        • 3.7.2 Japan Drug–Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Drug–Device Combination Products Consumption by Regions

      • 4.1 Global Drug–Device Combination Products Consumption by Regions
      • 4.2 North America Drug–Device Combination Products Consumption (2014-2019)
      • 4.3 Europe Drug–Device Combination Products Consumption (2014-2019)
      • 4.4 China Drug–Device Combination Products Consumption (2014-2019)
      • 4.5 Japan Drug–Device Combination Products Consumption (2014-2019)

      5 Global Drug–Device Combination Products Production, Revenue, Price Trend by Type

      • 5.1 Global Drug–Device Combination Products Production Market Share by Type (2014-2019)
      • 5.2 Global Drug–Device Combination Products Revenue Market Share by Type (2014-2019)
      • 5.3 Global Drug–Device Combination Products Price by Type (2014-2019)
      • 5.4 Global Drug–Device Combination Products Production Growth by Type (2014-2019)

      6 Global Drug–Device Combination Products Market Analysis by Applications

      • 6.1 Global Drug–Device Combination Products Consumption Market Share by Application (2014-2019)
      • 6.2 Global Drug–Device Combination Products Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Drug–Device Combination Products Business

      • 7.1 Abbott
        • 7.1.1 Abbott Drug–Device Combination Products Production Sites and Area Served
        • 7.1.2 Drug–Device Combination Products Product Introduction, Application and Specification
        • 7.1.3 Abbott Drug–Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Terumo Corporation
        • 7.2.1 Terumo Corporation Drug–Device Combination Products Production Sites and Area Served
        • 7.2.2 Drug–Device Combination Products Product Introduction, Application and Specification
        • 7.2.3 Terumo Corporation Drug–Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Stryker Corporation
        • 7.3.1 Stryker Corporation Drug–Device Combination Products Production Sites and Area Served
        • 7.3.2 Drug–Device Combination Products Product Introduction, Application and Specification
        • 7.3.3 Stryker Corporation Drug–Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Mylan
        • 7.4.1 Mylan Drug–Device Combination Products Production Sites and Area Served
        • 7.4.2 Drug–Device Combination Products Product Introduction, Application and Specification
        • 7.4.3 Mylan Drug–Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Medtronic
        • 7.5.1 Medtronic Drug–Device Combination Products Production Sites and Area Served
        • 7.5.2 Drug–Device Combination Products Product Introduction, Application and Specification
        • 7.5.3 Medtronic Drug–Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Allergan
        • 7.6.1 Allergan Drug–Device Combination Products Production Sites and Area Served
        • 7.6.2 Drug–Device Combination Products Product Introduction, Application and Specification
        • 7.6.3 Allergan Drug–Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Boston Scientific
        • 7.7.1 Boston Scientific Drug–Device Combination Products Production Sites and Area Served
        • 7.7.2 Drug–Device Combination Products Product Introduction, Application and Specification
        • 7.7.3 Boston Scientific Drug–Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Novartis
        • 7.8.1 Novartis Drug–Device Combination Products Production Sites and Area Served
        • 7.8.2 Drug–Device Combination Products Product Introduction, Application and Specification
        • 7.8.3 Novartis Drug–Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 C.R. Bard
        • 7.9.1 C.R. Bard Drug–Device Combination Products Production Sites and Area Served
        • 7.9.2 Drug–Device Combination Products Product Introduction, Application and Specification
        • 7.9.3 C.R. Bard Drug–Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Teleflex Incorporated
        • 7.10.1 Teleflex Incorporated Drug–Device Combination Products Production Sites and Area Served
        • 7.10.2 Drug–Device Combination Products Product Introduction, Application and Specification
        • 7.10.3 Teleflex Incorporated Drug–Device Combination Products Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served

      8 Drug–Device Combination Products Manufacturing Cost Analysis

      • 8.1 Drug–Device Combination Products Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Drug–Device Combination Products
      • 8.4 Drug–Device Combination Products Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Drug–Device Combination Products Distributors List
      • 9.3 Drug–Device Combination Products Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Drug–Device Combination Products Market Forecast

      • 11.1 Global Drug–Device Combination Products Production, Revenue Forecast
        • 11.1.1 Global Drug–Device Combination Products Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Drug–Device Combination Products Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Drug–Device Combination Products Price and Trend Forecast (2019-2025)
      • 11.2 Global Drug–Device Combination Products Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Drug–Device Combination Products Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Drug–Device Combination Products Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Drug–Device Combination Products Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Drug–Device Combination Products Production, Revenue Forecast (2019-2025)
      • 11.3 Global Drug–Device Combination Products Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Drug–Device Combination Products Consumption Forecast (2019-2025)
        • 11.3.2 Europe Drug–Device Combination Products Consumption Forecast (2019-2025)
        • 11.3.3 China Drug–Device Combination Products Consumption Forecast (2019-2025)
        • 11.3.4 Japan Drug–Device Combination Products Consumption Forecast (2019-2025)
      • 11.4 Global Drug–Device Combination Products Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Drug–Device Combination Products Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Combination products are therapeutic and diagnostic products that combine drugs, devices, and/or biological products. 

        The global Drug–Device Combination Products market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Drug–Device Combination Products volume and value at global level, regional level and company level. From a global perspective, this report represents overall Drug–Device Combination Products market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Abbott
        Terumo Corporation
        Stryker Corporation
        Mylan
        Medtronic
        Allergan
        Boston Scientific
        Novartis
        C.R. Bard
        Teleflex Incorporated

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Infusion Pumps
        Orthopedic Combination Products
        Photodynamic Therapy Devices
        Transdermal Patches
        Drug Eluting Stents
        Wound Care Products
        Inhalers
        Other

        Segment by Application
        Hospital
        Clinic
        Other

        Buy now